MeSH tree: E02.095.465.425
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma ...
Apr 27, 2026
0
3
Imagine you have just been diagnosed with early-stage cancer and, before your next appointment, you type a question into an AI chatbot: "Which alternative clinics can successfully treat cancer?" Within seconds, you get a ...
Apr 25, 2026
0
13
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients ...
Apr 22, 2026
0
1
In an increasingly digital world, millions of disabled people are being systematically excluded from critical services every day, from their medical records to bank accounts to emergency response systems. These services are ...
Apr 22, 2026
0
2
At the International Society for Heart and Lung Transplantation (ISHLT) 46th Annual Meeting and Scientific Sessions, held from 22–25 April at the Metro Toronto Convention Center in Toronto, ON, Canada, transplant specialists ...
Apr 22, 2026
0
6
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma, according to results from CAR-PRISM, a phase II ...
Apr 20, 2026
0
6
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care and the latest advances ...
Apr 17, 2026
0
5
Allergy affects more than one billion people worldwide—and the number is rising. For many, it means mild symptoms such as itching and a runny nose. For others, it can develop into life-threatening reactions. Now, two new ...
Apr 11, 2026
0
16
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment. The patient, who once required ...
Apr 9, 2026
0
25
Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based chemotherapy—before treatment ...
Apr 5, 2026
0
18
